VideoHIVHIV DART and Emerging Viruses 2016Collateral Damage with Antiviral Therapy | David Thomas, MD, MPHView Video
SLScott LetendreMDVideoHIVHIV DART and Emerging Viruses 2016Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MDView Video
MWMark WainbergMDVideoHIVHIV DART and Emerging Viruses 2016Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MDView Video
VideoHIVHIV DART and Emerging Viruses 2016HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2016David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhDView Video
RSRaymond SchinaziPhD, DScVideoHIVHIV DART and Emerging Viruses 2016Presentation of David Barry DART Achievement Award | Raymond Schinazi, PhD, DScView Video
SlidesetHIVHIV DART and Emerging Viruses 2016Collateral Damage with Antiviral Therapy | David Thomas, MD, MPHView Slideset
SLScott LetendreMDSlidesetHIVHIV DART and Emerging Viruses 2016Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MDView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2016(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. CallebautView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2016(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. BaughView Slideset
MWMark WainbergMDSlidesetHIVHIV DART and Emerging Viruses 2016Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MDView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2016(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. TaziView Slideset
